# A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer

> **NCT00378313** · PHASE2 · COMPLETED · sponsor: **NSABP Foundation Inc** · enrollment: 76 (—)

## Conditions studied

- Stage IIB Breast Cancer
- Stage IIIA Breast Cancer
- Stage IIIB Breast Cancer
- Stage IV Breast Cancer
- Breast Cancer
- Locally Advanced

## Interventions

- **DRUG:** gemcitabine, epirubicin, paclitaxel

## Key facts

- **NCT ID:** NCT00378313
- **Lead sponsor:** NSABP Foundation Inc
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** 76 (—)
- **Last updated:** 2008-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00378313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00378313, "A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00378313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*